Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
InteractionPUDP interactions

PGM3 IFT140

2.58e-046282int:PUDP
InteractionIFT122 interactions

DEF8 IFT140

3.01e-046782int:IFT122
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5

CTCFL DEF8 MYO1G

7.35e-0520793Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5
ToppCellStriatum-Hematopoietic-MICROGLIA-MI2(C1qb)|Striatum / BrainAtlas - Mouse McCarroll V32

CTCFL MYO1G

9.54e-0574920dbce0b36eaf0c7a8b623478c85d1cac82c6693a
ToppCellStriatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Striatum / BrainAtlas - Mouse McCarroll V32

CTCFL MYO1G

9.54e-057492093575ea862f3724d236817f04d98cc06b8addf0
ToppCellStriatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Striatum / BrainAtlas - Mouse McCarroll V32

CTCFL MYO1G

9.54e-057492b14a950b90791a4cc5ffd29eb75a524abdd382da
ToppCellStriatum-Hematopoietic-MICROGLIA|Striatum / BrainAtlas - Mouse McCarroll V32

CTCFL MYO1G

9.54e-05749289effada90fbfef1844a905d3f82e9d16666eea5
ToppCellStriatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Striatum / BrainAtlas - Mouse McCarroll V32

CTCFL MYO1G

9.54e-057492e89506bd854a43b80f839ace36f7a3eaa8437215
ToppCelldroplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1G IFT140

2.81e-0412792983489a69d3b1f1fe21110a862ac1dba53e9d31c
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

WSCD1 EGF

4.23e-04156921928c86deb3bcd01db4ae76919a351066aadb39a
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

WSCD1 EGF

4.40e-041599251a7322efead3d4978e8f9fef71302bfae96edd7
ToppCellPCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYO1G EGF

4.45e-041609208696d93ff42a1beca23c70ab3e0d082cfff4aa7
ToppCell15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class

CTCFL EGF

4.56e-0416292e190c496ed1e206b86566edfee23c99a99fe90d0
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

WSCD1 EGF

4.90e-0416892237a6a6e3bd3ed0e9f24a964b939bfdad442fc19
ToppCellfacs-Skin-Skin_Anagen-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1G WSCD1

4.96e-04169926f765e142d127545e622fe24b5287cd6e9706ccc
ToppCellfacs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1G WSCD1

4.96e-0416992630d921aa8fb5681d06a4e09b833855c374be484
ToppCellBronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

MYO1G IGLV1-47

4.96e-0416992dc388f660f69e37e517bf3243daf071ab138ee6e
ToppCellfacs-Skin-Skin_Anagen-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1G WSCD1

4.96e-0416992468284d4a3a0557aed04eadb1aba2317babc6904
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

MFSD12 MYO1G

5.20e-04173927714d27e53b02af4e071154cf2ea001fab347235
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

WSCD1 EGF

5.26e-0417492fdadac1eaab2c4a67e4832f0901df22e893add6a
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

WSCD1 EGF

5.26e-04174928d8cf8ad17dcc364f867e36b10834a21c0e36ad2
ToppCell11.5-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class

CTCFL MYO1G

5.32e-0417592d8ca8fbe5309dab293c335b32f1b138edfdd0b07
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGLV1-47 PGM3

5.50e-0417892693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGLV1-47 PGM3

5.50e-04178926765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WSCD1 EGF

5.56e-0417992abc6797bd3884aa75dca58fcb2523ee321243ab1
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WSCD1 EGF

5.56e-04179920b996d6e881f31e6b80d359f7caac70ecdeb9982
ToppCellPCW_13-14-Hematologic_ErythroMegGranulo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYO1G EGF

5.75e-0418292e5e16abf4d3bd5a97e7c573b99f7a3d9a5add120
ToppCell15-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class

MYO1G EGF

5.88e-0418492c294cd421f277992b56ae9c40b8f3948e33148fe
ToppCellwk_08-11-Hematologic_Lymphocytic-B-Immature_B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

MYO1G IGLV1-47

5.88e-0418492e6669a1b7ea7e4f8e094add5117689470019d85d
ToppCelldroplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WSCD1 EGF

5.94e-0418592af86e75096c1812ae27a78405355957ee8043d84
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DEF8 MYO1G

6.07e-0418792d69f4eee0304a7db226275ab77fc9d5d2b6f3a07
ToppCellE18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

WSCD1 IFT140

6.07e-04187923699d5e71d779da922920aa3160895db187bf81b
ToppCellE18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

WSCD1 IFT140

6.07e-0418792033ba52c0c2f9978784947098fa697368ae44834
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MFSD12 MYO1G

6.20e-04189929e3c083174a64ea78648c6d48498fc4e721b569f
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MFSD12 MYO1G

6.20e-04189926e19bfa52406ebe095daa99f958ec4d596ce6e39
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTCFL WSCD1

6.20e-0418992fccadf8efbef17b7f12291b069c71060a71b04e2
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class

IGLV1-47 PGM3

6.87e-041999246f31aef26c3da7608082f750d743ad54adbc51a
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1|Neuronal / cells hierarchy compared to all cells using T-Statistic

WSCD1 EGF

6.93e-0420092e1fca7ee2dc18c7fded53c3561f519c1fcd9767a
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic

WSCD1 EGF

6.93e-04200924409471479dd7c0f770bcb84ba7b3652c4706743
Drugnovobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A

MFSD12 PGM3 WSCD1

3.51e-0519883342_DN
DrugNomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A

MFSD12 WSCD1 EGF

3.51e-05198836362_DN
DrugAC1NE222

PGM3 EGF

2.22e-046582CID004635324
Drugbaron

CTCFL EGF

3.28e-047982CID000008686
DrugAC1NS1NG

PGM3 EGF

1.13e-0314782CID005327099
DrugPhenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A

PGM3 EGF

1.58e-03174825248_UP
DrugCortisporin

DEF8 EGF

1.63e-0317782CID000004454
DrugRaloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A

PGM3 IFT140

1.74e-03183823480_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

WSCD1 EGF

1.80e-03186825585_UP
DrugCyclosporin A [59865-13-3]; Up 200; 3.4uM; HL60; HT_HG-U133A

DEF8 PGM3

1.86e-03189821331_UP
Druggeldanamycin; Up 200; 1uM; MCF7; HG-U133A

PGM3 WSCD1

1.86e-0318982611_UP
DrugEconazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A

MFSD12 EGF

1.88e-03190827305_DN
Drug2-propylpentanoic acid; Up 200; 10000uM; HL60; HG-U133A

MFSD12 PGM3

1.88e-0319082410_UP
DrugClioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A

WSCD1 EGF

1.88e-03190825623_UP
DrugPiromidic acid [19562-30-2]; Down 200; 13.8uM; HL60; HT_HG-U133A

PGM3 IFT140

1.94e-03193822996_DN
DrugSimvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A

WSCD1 EGF

1.94e-03193823340_UP
DrugHymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A

EGF IFT140

1.94e-03193824623_DN
DrugFlutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A

WSCD1 EGF

1.96e-03194823885_UP
DrugEstrone [53-16-7]; Up 200; 14.8uM; HL60; HT_HG-U133A

PGM3 IFT140

1.96e-03194823071_UP
DrugNorethynodrel [68-23-5]; Up 200; 13.4uM; HL60; HT_HG-U133A

PGM3 WSCD1

1.96e-03194821860_UP
DrugF0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A

WSCD1 EGF

1.96e-03194826424_UP
Drug2-propylpentanoic acid; Up 200; 1000uM; HL60; HG-U133A

MFSD12 PGM3

1.96e-0319482409_UP
DiseasePrecancerous Conditions

WSCD1 EGF

4.87e-0411092C0032927
DiseaseCondition, Preneoplastic

WSCD1 EGF

4.87e-0411092C0282313
Diseaseskin pigmentation measurement

MFSD12 DEF8

7.54e-0413792EFO_0007009
Diseaseskin aging measurement

MFSD12 DEF8

1.31e-0318192EFO_0008006
Diseaseobsolete aging

MYO1G WSCD1

3.07e-0327992GO_0007568

Protein segments in the cluster

PeptideGeneStartEntry
RCCSFDGDADRIVYY

PGM3

271

O95394
HAYSAAELKCRYCSA

CTCFL

451

Q8NI51
SGLRSEDEADYYCAA

IGLV1-47

96

P01700
CAEGYALSRDRKYCE

EGF

341

P01133
ADCSAVFHRDCYYDN

DEF8

471

Q6ZN54
LEASADCSRALSYYE

IFT140

911

Q96RY7
VGYEADRAASCCARY

MFSD12

76

Q6NUT3
DACAERSYVYAGLEA

WSCD1

176

Q658N2
AEASYARDACAKAVY

MYO1G

346

B0I1T2